EUVIMEDEUVIMED entdecken
Crossref

Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways

Nikita Pal, Rahul Kesarwani, Tapas K Mandal, Krishna P Bhabak iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.5c02154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Nikita Pal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Organoselenium Compounds, Breast Neoplasms, Reactive Oxygen Species. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Indian Institute of Technology Guwahati, Science and Engineering Research Board, Ministry of Education, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOrganoselenium CompoundsBreast NeoplasmsReactive Oxygen SpeciesBiocompatible MaterialsIsocyanatesHumansCell ProliferationDrug Screening Assays, AntitumorSignal TransductionApoptosisFemaleMolecular StructureStructure-Activity RelationshipDose-Response Relationship, DrugMCF-7 Cells

Stichwörter der Autor:innen

NBDHEXbreast cancerglutathione-S-transferase Pi (GSTP1)organoselenocyanatesreactive oxygen species (ROS)

Substanzen

Antineoplastic AgentsOrganoselenium CompoundsReactive Oxygen SpeciesBiocompatible MaterialsIsocyanates

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
  • Department of Chemical Engineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.

ORCID-Profile: Krishna P Bhabak

Förderung

  • Indian Institute of Technology Guwahati
  • Science and Engineering Research Board
  • Ministry of Education, India

Zitieren

APA

Pal, N., Kesarwani, R., Mandal, T. K., & Bhabak, K. P. (2025). Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c02154

Vancouver

Pal N, Kesarwani R, Mandal TK, Bhabak KP. Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c02154

BibTeX
@article{Pal2025,
  author = {Pal, Nikita and Kesarwani, Rahul and Mandal, Tapas K and Bhabak, Krishna P},
  title = {Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.5c02154}
}
Kostenlos starten →